# Anakinra to Prevent Post-infarction Remodeling

> **NCT00789724** · PHASE3 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 10 (actual)

## Conditions studied

- ST Segment Elevation Acute Myocardial Infarction

## Interventions

- **DRUG:** Anakinra
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00789724
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789724, "Anakinra to Prevent Post-infarction Remodeling". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00789724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*